Related Experiment Video

Updated: Feb 20, 2026

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

1.6K

Integration of nano drug-delivery system with cancer immunotherapy

Takashi Nakamura1, Hideyoshi Harashima1

  • 1Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12 Nishi 6, Kita-ku, Sapporo, Hokkaido 060-0812, Japan.

Therapeutic Delivery
|October 25, 2017
PubMed

Insights

Immune checkpoint inhibitors show promise but benefit few patients. Combining them with nanotechnology-based drug delivery systems (nano DDS) may improve cancer immunotherapy effectiveness by targeting tumor microenvironments.

Area of Science:

  • Oncology
  • Immunology
  • Nanotechnology

Background:

  • Immune checkpoint inhibitors (ICIs) offer revolutionary cancer therapy but benefit a limited patient subset.
  • Improving and broadening clinical response to ICIs is a critical challenge in oncology.
  • Combination therapies involving ICIs are under active investigation to enhance efficacy.

Purpose of the Study:

  • To review recent advancements in tumor immunology relevant to combination cancer therapy.
  • To discuss nanotechnology-based drug delivery systems (nano DDS) in cancer immunotherapy.
  • To explore nano DDS strategies tailored to the immune status of tumor microenvironments.

Main Methods:

  • Literature review of tumor immunology findings.
  • Analysis of nanotechnology applications in cancer immunotherapy.
  • Examination of nano DDS strategies based on tumor microenvironment immunology.

Main Results:

  • Emerging evidence suggests combination therapies are key to overcoming ICI limitations.
  • Nanotechnology-based drug delivery systems offer a promising platform for enhancing ICI efficacy.
  • Tailoring nano DDS to specific tumor immune microenvironments can optimize treatment outcomes.

Conclusions:

  • Combining immune checkpoint inhibitors with nanotechnology-based drug delivery systems presents a viable strategy to improve cancer treatment.
  • Further research into nano DDS tailored to tumor microenvironments is crucial for advancing cancer immunotherapy.
  • Nanotechnology holds significant potential for overcoming current challenges in immune checkpoint therapy.
Keywords:
STINGadjuvantcancer immunotherapydrug-delivery systemimmune checkpoint inhibitorlipid nanoparticlenanotechnologynucleic acid

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.5K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
34